Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

903.58 +7.99 (+0.89%)
Official Closing Price Updated: 7:00 PM EDT, Oct 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,187,512
Open 898.21
Bid (Size) 915.00 (1)
Ask (Size) 917.00 (20)
Prev. Close 895.59
Today's Range 898.21 - 907.98
52wk Range 547.61 - 972.53
Shares Outstanding N/A
Dividend Yield 0.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly Says New Data Can Potentially Provide Path To Improved Donanemab Profile By Lower Risk Of Imaging Abnormalities In Patients With Early Alzheimer's
Eli Lilly's Phase 3b study reveals a 41% reduction in amyloid-related imaging abnormalities in Alzheimer's patients using a modified titration of donanemab. 
Via Benzinga
Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains
Eli Lilly reports Q3 earnings on Wednesday. Stock up 58% in past year, potential to split to attract investors in growing weight loss market. 
Via Benzinga

Performance

YTD
+52.58%
+52.58%
1 Month
+1.99%
+1.99%
3 Month
+14.35%
+14.35%
6 Month
+15.68%
+15.68%
1 Year
+59.72%
+59.72%

More News

Read More
A Closer Look at Eli Lilly's Options Market Dynamics
Via Benzinga
Will New CFO Offer Annual Guidance For Google Stock?
Via Investor's Business Daily
1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever
Via The Motley Fool
Eli Lilly's Latest Setback Could Portend an Unexpected Headwind for the Stock
Via The Motley Fool
$1000 Invested In This Stock 20 Years Ago Would Be Worth $16,000 Today
Via Benzinga
Decoding Eli Lilly's Options Activity: What's the Big Picture?
Via Benzinga
Neuralink's Promise For Alzheimer's Has A Crucial Time Window — Elon Musk Explains Why
Via Benzinga
Eli Lilly's Mirikizumab Shows Long-Term Sustained Efficacy, Safety For Ulcerative Colitis And Crohn's Disease
Via Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Via The Motley Fool
What Lies In Store For Healthcare ETFs In Q3 Earnings?
Via Talk Markets
Topics ETFs
Billionaire Stanley Druckenmiller Closed Out His Position in Eli Lilly Stock. 3 Reasons Why I'm Still a Buyer.
Via The Motley Fool
2 Soaring Growth Stocks That Are Still Worth Buying
Via The Motley Fool
Tesla To Rally Over 21%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
Via Benzinga
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
Via Investor's Business Daily
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Via Benzinga
Gary Black Fights Off Criticism, Says Worst Peformer In Future Fund Was Tesla — Here Are His Holdings That Did Better
Via Benzinga
How Viking Therapeutics Just Dealt A Blow To Eli Lilly's Obesity Triplet
Via Investor's Business Daily
Exposures Product Safety
Jim Cramer Says He Would Not Buy This Health Care Stock At This Level: 'Wait For A Pullback'
Via Benzinga
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Via Benzinga
Exposures Product Safety
Eli Lilly Alzheimer's Drug Faces Tough Road In UK, Price Watchdog NICE Says Donanemab Is Not Cost-Effective
Via Benzinga
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
Via The Motley Fool
Topics ETFs
This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.